At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
03681 SINOMAB BIO-B
Closed Christmas Day 12-24 09:50:22
1.100
+0.010
+0.92%
High1.100
Low1.100
Vol0.00
Open1.100
D1 Closing1.090
Amplitude0.00%
Mkt Cap1.20B
Tradable Cap1.20B
Total Shares1.09B
T/O0.00
T/O Rate0.00%
Tradable Shares1.09B
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
SinoMab BioScience Limited's (HKG:3681) market cap dropped HK$175m last week; Retail investors bore the brunt
SinoMab BioScience Ltd is a Hong Kong-based biopharmaceutical company mainly dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases. The Company primarily develops mAb-based biologics and new chemical entities (NCE). The Company’s product SM03 is a mAb for the treatment of rheumatoid arthritis (RA). The Company is developing drugs for the treatment of RA, systemic lupus erythematosus (SLE), asthma, pemphigus, sjogren’s syndrome (SS) and other immunological diseases.